- Home
- PSNYW vs EBS Comparison
PSNYW vs EBS Comparison
Compare PSNYW & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- EBS
- Stock Information
- Founded
- PSNYW 2017
- EBS 1998
- Country
- PSNYW Sweden
- EBS United States
- Employees
- PSNYW N/A
- EBS N/A
- Industry
- PSNYW Auto Manufacturing
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- PSNYW Consumer Discretionary
- EBS Health Care
- Exchange
- PSNYW Nasdaq
- EBS Nasdaq
- Market Cap
- PSNYW 352.9M
- EBS 393.9M
- IPO Year
- PSNYW N/A
- EBS 2006
- Fundamental
- Price
- PSNYW $0.17
- EBS $4.62
- Analyst Decision
- PSNYW
- EBS Strong Buy
- Analyst Count
- PSNYW 0
- EBS 3
- Target Price
- PSNYW N/A
- EBS $14.33
- AVG Volume (30 Days)
- PSNYW 79.9K
- EBS 1.3M
- Earning Date
- PSNYW 03-06-2025
- EBS 04-30-2025
- Dividend Yield
- PSNYW N/A
- EBS N/A
- EPS Growth
- PSNYW N/A
- EBS N/A
- EPS
- PSNYW N/A
- EBS N/A
- Revenue
- PSNYW $2,046,740,000.00
- EBS $1,043,600,000.00
- Revenue This Year
- PSNYW N/A
- EBS N/A
- Revenue Next Year
- PSNYW $77.28
- EBS $19.88
- P/E Ratio
- PSNYW N/A
- EBS N/A
- Revenue Growth
- PSNYW N/A
- EBS N/A
- 52 Week Low
- PSNYW $0.09
- EBS $1.82
- 52 Week High
- PSNYW $0.61
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- PSNYW 47.73
- EBS 39.12
- Support Level
- PSNYW $0.16
- EBS $4.13
- Resistance Level
- PSNYW $0.18
- EBS $4.79
- Average True Range (ATR)
- PSNYW 0.02
- EBS 0.44
- MACD
- PSNYW 0.00
- EBS 0.11
- Stochastic Oscillator
- PSNYW 72.28
- EBS 41.67
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market-leading standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from USA.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.